Pharma Marketing Network

This article is a review of the proposed FDA 'Experimental Study of Direct-to-Consumer Promotion Directed at Adolescents' (FR # FDA-2013-N-1151), which aims to assess how adolescents interpret drug risk in DTC advertising.

This article reviews the study 'Examination of Online Direct-to-Consumer Prescription Drug Promotion' (FDA-2011-N-0230), which is designed to test different ways of presenting prescription drug risk and benefit information on branded drug Web sites.

Welcome to Volume 13, Issue #10 (DECEMBER 2014) of Pharma Marketing News.

I try to keep track of how money the U.S. pharmaceutical industry spends on digital advertising to see if there are any trends. Of...

According to the latest estimate from Tufts economists, it now costs upwards of $2.6 billion to bring a new prescription drug to market (read...

According to a new study by the Tufts Center for the Study of Drug Development (CSDD), which receives funding from the pharmaceutical industry, the...

Rx Drug Personalities Perceived by Consumers

FDA Wants to Peek Into Your Bedroom to Learn If Your Spouse Affects Your Perception of Risks in Those New Viagra TV Ads!

The FDA plans to to study the "Impact of Ad Exposure Frequency on Perception and Mental Processing of Risk and Benefit Information in DTC...

Today, I learned about a Twitter app called Samaritans Radar that was "pulled" because it took social media "listening" a step too far. According...